Socialiya - Entertainment. Knowledge. Community.
Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds

Eli Lilly's GLP-1 ​drug tirzepatide yields greater weight loss on average than Novo Nordisk's semagl...

HEALTH NEWS April 16, 2026

Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds

Eli Lilly's GLP-1 ​drug tirzepatide yields greater weight loss on average than Novo Nordisk's semaglutide, but at a greater expense ‌to muscles and...

15 views 0 likes 0 comments
Share:
Eli Lilly's GLP-1 ​drug tirzepatide yields greater weight loss on average than Novo Nordisk's semaglutide, but at a greater expense ‌to muscles and...

Author: Reuters

Read Original Article

Related News

Advertisement
socialiya
Advertisement
APNA POS
Advertisement

Top Categories

Advertisement
APNA POS
Advertisement
socialiya
Advertisement
socialiya
Advertisement
APNA POS